KYNTRA BIO, INC. (KYNB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 90M 180M 270M FY13: 102.2M FY14: 137.6M FY15: 180.8M FY16: 183.2M FY17: 131M FY18: 213M FY19: 256.6M FY20: 176.3M FY21: 235.3M FY22: 140.7M FY23: 46.8M FY24: 29.6M FY25: 6.4M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 90M 180M 270M FY19: 255.4M FY20: 167.4M FY21: 222.4M FY22: 120.5M FY23: 42.8M FY24: 14.1M FY25: 5.9M FY19 FY20 FY21 FY22 FY23 FY24 FY25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

-450M -300M -150M 0 150M 300M 450M FY13: -7.9M FY14: -50.1M FY15: -77.6M FY16: -50M FY17: -117.3M FY18: -86.7M FY19: -89.3M FY20: -191.9M FY21: -288.5M FY22: -301M FY23: -322.7M FY24: -150.4M FY25: -45.9M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-300M -200M -100M 0 100M 200M 300M FY13: -14.9M FY14: -59.5M FY15: -85.8M FY16: -58.1M FY17: -120.9M FY18: -86.4M FY19: -77M FY20: -189.3M FY21: -290M FY22: -293.7M FY23: -284.2M FY24: -47.6M FY25: 183.5M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 7M 14M 21M FY19: 1.1M FY20: 8.9M FY21: 12.9M FY22: 20.3M FY23: 4M FY24: 15.6M FY25: 556K FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-450M -300M -150M 0 150M 300M 450M FY13: 25.9M FY14: 22.4M FY15: -18.6M FY16: 7.1M FY17: -66.5M FY18: -76.1M FY19: -78.7M FY20: 81.6M FY21: -82.2M FY22: -145.9M FY23: -315M FY24: -138M FY25: -4.8M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-450M -300M -150M 0 150M 300M 450M FY13: 19.1M FY14: 14.3M FY15: -20.5M FY16: 5.9M FY17: -75M FY18: -84.2M FY19: -84.5M FY20: 77.6M FY21: -87.4M FY22: -149.7M FY23: -317.5M FY24: -138.3M FY25: -4.8M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 35M 70M 105M FY20: 89.9M FY21: 92.3M FY22: 93.6M FY23: 97.3M FY24: 4M FY25: 4M FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-20.00 0.00 20.00 40.00 60.00 Q4 '14: -6.08 Q1 '15: -5.63 Q2 '15: -5.38 Q3 '15: -3.19 Q4 '15: -1.54 Q1 '16: -1.21 Q2 '16: -1.69 Q3 '16: -1.33 Q4 '16: -0.97 Q1 '17: -1.00 Q2 '17: -1.83 Q3 '17: -1.77 Q4 '17: -1.70 Q1 '18: -1.72 Q2 '18: -1.52 Q3 '18: -1.70 Q4 '18: -1.03 Q1 '19: -1.06 Q2 '19: 0.48 Q3 '19: 0.41 Q4 '19: -0.89 Q1 '20: -1.25 Q2 '20: -3.46 Q3 '20: -2.54 Q4 '20: -2.14 Q1 '21: -2.03 Q2 '21: -2.53 Q3 '21: -2.34 Q4 '21: -3.14 Q1 '22: -3.04 Q2 '22: -2.37 Q3 '22: -3.89 Q4 '22: -3.15 Q1 '23: -3.28 Q2 '23: -3.40 Q3 '23: -3.07 Q4 '23: -2.93 Q1 '24: -2.45 Q2 '24: -5.44 Q3 '24: -9.04 Q4 '24: -11.89 Q1 '25: -10.41 Q2 '25: -8.40 Q3 '25: 45.46 Q4 '25: 45.37 Q1 '26: 40.46 Q2 '26: 45.30 Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.